|Articles|July 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-07-02-2003
  • Volume 27
  • Issue 7

Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance

Pharmaceutical companies must take a holistic look at their systems and supporting processes to implement FDA's risk-based approach into their 21 CFR Part 11 complaince strategies.
External Link - article-62502.pdf

Articles in this issue

over 22 years ago

July 2003

over 22 years ago

Gastrorentention: A Means to Address Regional Variability in Intestinal Drug Absorption

over 22 years ago

The Push for Generics Challenges Manufacturers

over 22 years ago

Emerging Research Opportunities in Oral Inhalation Technology

over 22 years ago

Preventing Metal Contamination

over 22 years ago

Capacity Worries Fade for Biomanufacturing

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!